Isotretinoin: an expert review of suspected psychiatric and sexual side effects –call for information from patients, patient representatives, healthcare professionals, researchers, and organisations

The MHRA is seeking views on place in therapy of isotretinoin in acne treatment, risks associated with use, measures currently in place to reduce risks and what further measures could be taken to optimise the safe use of isotretinoin and raise awareness of potential risks.

Source:

Medicines and Healthcare products Regulatory Agency